Asensitivity Surgical, Inc., originally established as an NCS joint venture on August 19, 1988, is a medical device company specializing in the development and sale of robot-assisted surgical systems. Asensitivity Surgical, Inc., is digitizing the interface between surgeons and patients to usher in a new era of performance-directed surgery by unlocking clinical intelligence, consistently delivering superior therapeutic outcomes and new surgical standards. This builds on digital laparoscopic technology, a system that enhances the surgeon's control and reduces surgical variability. By adding machine vision, enhanced intelligence and deep learning capabilities throughout the surgical process, the company intends to address the clinical, cognitive and economic deficiencies that currently drive surgical outcomes and value-based healthcare as a whole. 

ASXC(Delisted)